LEADER 01982oam  2200541   450 
001 9910708177003321
005 20151002144207.0
035   $a(CKB)3790000000047614
035   $a(OCoLC)796908185$z(OCoLC)654961738$z(OCoLC)655190478
035   $a(EXLCZ)993790000000047614
100   $a20120625d1999      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCutting edge issues in drug testing and drug treatment $ehearing before the Subcommittee on National Security, International Affairs, and Criminal Justice of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, June 5, 1998
210  1$aWashington :$cU.S. Government Printing Office,$d1999.
215   $a1 online resource (iii, 177 pages) $cillustrations
300   $aTitle from title screen (viewed on Oct. 2, 2015).
300   $a"Serial no. 105-182."
320   $aIncludes bibliographical references.
517   $aCutting edge issues in drug testing and drug treatment 
606   $aEmployees$xDrug testing$zUnited States
606   $aDrug testing$zUnited States
606   $aDrug abuse$xTreatment$zUnited States
606   $aDrug abuse$xTreatment$2fast
606   $aDrug testing$2fast
606   $aEmployees$xDrug testing$2fast
607   $aUnited States$2fast
608   $aLegislative hearings.$2lcgft
615  0$aEmployees$xDrug testing
615  0$aDrug testing
615  0$aDrug abuse$xTreatment
615  7$aDrug abuse$xTreatment.
615  7$aDrug testing.
615  7$aEmployees$xDrug testing.
801  0$bOCLCE
801  1$bOCLCE
801  2$bOCLCQ
801  2$bOCLCF
801  2$bOCLCQ
801  2$bOCLCO
801  2$bGPO
906   $aBOOK
912   $a9910708177003321
996   $aCutting edge issues in drug testing and drug treatment$93523872
997   $aUNINA